You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for Patent: 4,803,081


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,803,081
Title: New pharmaceutical preparations with extended release
Abstract:An extended release perparation of an active compound with very low solubility containing the active compound dissolved or dispersed in a semi-solid or liquid non-ionic solubilizer and whereby the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound as well as a process for the preparation thereof.
Inventor(s): Falk; Karl-Erik L. (Lindome, SE), Hugosson; Sven M. (Kungsbacka, SE), Rosinski; Adam (Molndal, SE), Sjogren; John A. (Molnlycke, SE)
Assignee: Aktiebolaget Hassle (Molndal, SE)
Application Number:07/034,500
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process;

Drugs Protected by US Patent 4,803,081

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,803,081

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8601624Apr 11, 1986

International Family Members for US Patent 4,803,081

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 76288 ⤷  Sign Up
Australia 602677 ⤷  Sign Up
Australia 7004387 ⤷  Sign Up
Canada 1304294 ⤷  Sign Up
China 1025150 ⤷  Sign Up
China 87102758 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.